用于GMP级全提取大麻油的过程开发:朝着标准化医疗用途的方向
Maria do Céu Costa1,2, Ana Patrícia Gomes1,3, Iva Vinhas3
1CBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal.
Pharmaceutics
|July 30, 2025
概括
工业提取和净化Cannabis sativa L.化合物对于一致的治疗产品至关重要. 这项研究优化了最大限度地利用大麻素的过程,并改善了全谱提取大麻油 (FECO) 的感官属性.
科学领域:
- 制药科学 制药科学
- 自然产品化学 自然产品化学
- 感官科学 感官科学
背景情况:
- 工业提取和净化Cannabis sativa L.对于可再生的治疗和感官产品属性至关重要.
- 优化这些过程可确保大麻制剂的质量和有效性保持一致.
研究的目的:
- 为了化学分析和表征标准化Cannabis sativa L.制剂的感官属性.
- 评估深冷乙醇提取和擦拭膜蒸在保存大麻素和烯方面的有效性.
- 评估净化对全谱提取大麻油 (FECO) 感官质量和治疗功能的影响.
主要方法:
- 标准化化学型I 大麻sativa L. 制剂经过化学分析和感官评估.
- 用深冷乙醇进行选择性提取,然后在深真空 (<0.2 mbar) 下进行擦拭薄膜蒸以进行净化.
- 在各种加工阶段分析了原料和纯化FECO的cannabinoid和terpene概况.
主要成果:
- 尽管进行了脱碳化,但大麻素特征从草药物质保存到最终制剂.
- 纯化FECO在颜色和整体外观上获得了较高的接受度,而原始FECO则具有极化味道.
- 烯标记物得到了显著的保存,这表明了高度的可重复性和受控的重新引入的潜力.
结论:
- 工业净化过程有效地去除了非大麻素,提高了感官质量,同时保持了治疗功效.
- 纯化FECO表现出更好的感官接受度和一致的烯配置文件,这对于产品开发至关重要.
- 监测提取和净化对于优化大麻制剂中的大麻素含量和感官特征至关重要.
相关概念视频
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


